Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which are reported with a growing incidence during the last decade. Prognostic assessment may help to identify subgroups of patients that could benefit from more aggressive therapy of metastatic disease, in particular when central nervous system is involved. The recent sub-classification of non-small cell lung cancer (NSCLC) into molecularly-defined "oncogene-addicted" tumors, the emergence of effective targeted treatments in molecularly defined patient subsets, global improvement of advanced NSCLC survival as well as the availability of refined new radiotherapy techniques are likely to impact on outcomes of patients with brain dissemination. The ...
Metastatic tumors involving the brain are an important complication in the overall management of non...
Lung cancer is the most common primary malignancy that tends to metastasize to the brain. Owing to i...
With the improvements in systemic treatment for lung cancer, distant metastasis to sanctuary sites s...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Risk of brain metastases (BM) affects a remarkable number of non-small cell lung cancer (NSCLC) pati...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Brain metastases are common events in the natural course of many advanced solid cancers like breast,...
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and has high morbidity...
Brain metastases are common events in the natural course of many advanced solid cancers like breast,...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
Approximately 40% of lung cancer patients will develop central nervous system (CNS) metastases durin...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
Central nervous system (CNS) metastases are common among patients with non-small cell lung cancer (N...
Metastatic tumors involving the brain are an important complication in the overall management of non...
Lung cancer is the most common primary malignancy that tends to metastasize to the brain. Owing to i...
With the improvements in systemic treatment for lung cancer, distant metastasis to sanctuary sites s...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Risk of brain metastases (BM) affects a remarkable number of non-small cell lung cancer (NSCLC) pati...
Lung cancer is characterized by the highest incidence of solid tumor-related brain metastases, which...
Brain metastases are common events in the natural course of many advanced solid cancers like breast,...
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors and has high morbidity...
Brain metastases are common events in the natural course of many advanced solid cancers like breast,...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
Approximately 40% of lung cancer patients will develop central nervous system (CNS) metastases durin...
International audienceThe management of Non Small Cell Lung Cancer (NSCLC) brain metastases is chall...
Central nervous system (CNS) metastases are common among patients with non-small cell lung cancer (N...
Metastatic tumors involving the brain are an important complication in the overall management of non...
Lung cancer is the most common primary malignancy that tends to metastasize to the brain. Owing to i...
With the improvements in systemic treatment for lung cancer, distant metastasis to sanctuary sites s...